Estrella Immunopharma (ESLA) Earnings Date & Reports
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday alerts
A.I. Advisor
published Earnings
ESLA is expected to report earnings to fall 58.82% to -7 cents per share on March 03
Q4'26
Est.
$-0.07
Q3'26
Missed
by $0.09
Q2'26
Beat
by $0.12
Q1'26
Beat
by $0.13
Q2'25
Missed
by $0.04
The last earnings report on November 13 showed earnings per share of -17 cents, missing the estimate of -7 cents. With 107.65K shares outstanding, the current market capitalization sits at 16.32M.